The Future of Biologics Contract Manufacturing

What is changing in the biologics CMO industry and how does that impact speed and cost to market for new products? Outsourcing is exploding in the biopharmaceutical world as large pharmaceutical companies exercise reductions in capital spending while increasing their pipeline of products. At the same time, smaller pharmaceutical companies are working with limited funding to build their own capacity and are reaching outward to contract solutions. Contract Manufacturing Organizations (CMOs) are ready to provide supporting services at every level from cell line development, through establishment of processes. Understand new services that are available to bring new products to market.